SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AURX

Nuo Therapeutics, Inc. (OTC:AURX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.91-$0.16 (-14.83%)
 
Market cap
$44.4M
Insider Score
Health Score
Listed since
Oct 24, 2017
Website
Market Cap$44.38M-60.1%
Revenue (ttm)$6.03M+131.1%
Net Income-$1.90M+21.8%
EPS-$0.04+24.0%
Shares Out48.59M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,100
Open$1.05
Previous Close$1.07
Day's Range$0.91 - $1.05
52-Week Range$0.77 - $2.29
Betan/a
Analystsn/a
Price Target$3.00(+228.41%)
Earnings DateMar 3, 2027
-15.15% (1D)
No price history available.

About AURX

Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.

Address
8285 El Rio, Houston, TX, 77054, US
Market Cap
44 million
Employees
10
Industrial Classification
Biotechnology

Nuo Therapeutics, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
30th Percentile Overall Score
AURX InsiderScore:60 / 99

Nuo Therapeutics, Inc. scored higher than 30% of companies evaluated by InsiderBuying, and ranked 60th out of 102 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Nuo Therapeutics, Inc. bought $9.5K of stock across 2 purchases in the last 90 days, the largest of them $8.7K.

Stake Increase

The average purchase added about 0% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$300.00K
Bought
$9.54K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Distressed
From AURX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-14.83%
5 Days
-16.19%
1 Month
-29.73%
6 Months
-17.70%
1 Year
-60.11%

$AURX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in AURX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by AURX's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

AURX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

AURX Revenue by Segment or Geography

AURX's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New AURX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AURX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from AURX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
57.85
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
2
Sells
1
Buy Value
$9.54K
Distinct Buyers
1

Insider Score Trend Over Time

-2.0 since Sep 24
0255075100Sep 24 — Insider Score 59.9Sep 25 — Insider Score 76.8Sep 26 — Insider Score 76.5Sep 27 — Insider Score 76.7Sep 28 — Insider Score 76.7Sep 29 — Insider Score 76.0Sep 30 — Insider Score 75.6Oct 1 — Insider Score 74.9Oct 2 — Insider Score 40.0Oct 3 — Insider Score 74.4Oct 4 — Insider Score 74.6Oct 5 — Insider Score 74.7Oct 6 — Insider Score 73.8Oct 7 — Insider Score 73.7Oct 8 — Insider Score 73.5Oct 9 — Insider Score 73.2Oct 10 — Insider Score 72.8Oct 11 — Insider Score 73.8Oct 12 — Insider Score 73.8Oct 13 — Insider Score 73.4Oct 14 — Insider Score 73.0Oct 15 — Insider Score 72.9Oct 16 — Insider Score 72.6Oct 17 — Insider Score 72.4Oct 18 — Insider Score 72.9Oct 19 — Insider Score 72.5Oct 20 — Insider Score 72.6Oct 21 — Insider Score 72.4Oct 22 — Insider Score 72.4Oct 23 — Insider Score 72.2Oct 24 — Insider Score 72.2Oct 25 — Insider Score 71.8Oct 26 — Insider Score 70.8Oct 27 — Insider Score 70.9Oct 28 — Insider Score 70.7Oct 29 — Insider Score 70.3Oct 30 — Insider Score 69.3Oct 31 — Insider Score 68.8Nov 1 — Insider Score 69.0Nov 2 — Insider Score 69.2Nov 3 — Insider Score 68.4Nov 4 — Insider Score 67.8Nov 5 — Insider Score 68.2Nov 6 — Insider Score 67.3Nov 7 — Insider Score 66.6Nov 8 — Insider Score 67.5Nov 9 — Insider Score 67.9Nov 10 — Insider Score 66.6Nov 11 — Insider Score 65.8Nov 12 — Insider Score 65.7Nov 13 — Insider Score 64.5Nov 14 — Insider Score 63.5Nov 15 — Insider Score 64.0Nov 16 — Insider Score 63.5Nov 17 — Insider Score 61.6Nov 18 — Insider Score 60.6Nov 19 — Insider Score 59.5Nov 20 — Insider Score 57.9Nov 21 — Insider Score 57.3Nov 22 — Insider Score 57.9Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.